Pura Vida Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-400,000
Closed -$44.4M 249
2022
Q1
$44.4M Buy
+400,000
New +$42.3M 1.44% 15
2021
Q4
Sell
-120,000
Closed -$15M 280
2021
Q3
$15M Buy
+120,000
New +$15.5M 0.46% 54
2021
Q1
Sell
-200,000
Closed -$23.4M 241
2020
Q4
$23.4M Sell
200,000
-20,000
-9% -$2.2M 0.85% 22
2020
Q3
$22.9M Buy
+220,000
New +$22.1M 1.18% 16
2020
Q2
Sell
-475,000
Closed -$42.8M 134
2020
Q1
$42.8M Buy
475,000
+209,000
+79% +$22.2M 5.09% 4
2019
Q4
$30.2M Buy
+266,000
New +$29.2M 2.65% 6
2019
Q1
Sell
-400,000
Closed -$36.4M 118
2018
Q4
$36.4M Buy
400,000
+300,000
+300% +$28M 7.26% 3
2018
Q3
$9.84M Buy
+100,000
New +$9.25M 2.07% 7

Other funds holding MDT

Pura Vida Investments's MDT Position: Q4 2018 in Review

Pura Vida Investments sold out of Medtronic (MDT) in Q4 2018, closing a stake of 81,027 shares — an estimated $7.57M sold.

Pura Vida Investments first reported a position in MDT in Q2 2016 and held it in 5 quarters. The position peaked at $7.97M in Q3 2018. 1,564 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • Pura Vida Investments reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • Pura Vida Investments sold 81,027 Medtronic shares in Q4 2018, an estimated $7.57M.
  • Pura Vida Investments first reported a position in Medtronic in Q2 2016 and held it in 5 quarters.
  • Pura Vida Investments's Medtronic position peaked at $7.97M in Q3 2018.
  • 1,564 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.